COVID-19 campus updates: COVID-19 at Dartmouth, in New Hampshire on the wane as spring term ends
thedartmouth.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thedartmouth.com Daily Mail and Mail on Sunday newspapers.
Argentina posts record number of coronavirus cases as Copa America nears
laprensalatina.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from laprensalatina.com Daily Mail and Mail on Sunday newspapers.
Argentina, Mexico hail vaccine partnership as boon for entire region 2 minutes read
Mexico City, May 25 (EFE).- An effort by Mexico and Argentina to jointly produce the vaccine developed by the University of Oxford-AstraZeneca will make Latin America’s immunization process less dependent on the rest of the world, Argentine President Alberto Fernandez said Tuesday in a video call with Mexican counterpart Andres Manuel Lopez Obrador.
He made that assertion after announcing during Lopez Obrador’s daily press conference that an initial batch of 800,000 doses of the AstraZeneca vaccine will be shipped to Argentina from Mexico this weekend after a months-long delay. An equal number of doses resulting from that initiative will be distributed simultaneously in Mexico.
THOUSANDS of people in Oxfordshire volunteered themselves as Guinea pigs to help with national and international efforts to create life-saving vaccines. Health bosses have thanked more than 7,000 participants who came forward for Covid-19 studies in the county since the beginning of the pandemic. A total of 7,647 residents played a vital role in 31 studies supported by the National Institute for Health Research (NIHR) in hospitals, care homes and GP practices across Oxfordshire. Among participants was Janice Rowan who took budesonide through an inhaler as part of the PRINCIPLE trial after testing positive for the virus in December. The 59-year-old, who is based in Banbury, was among 162 county people who got involved in the trial into whether a short course of existing drugs can reduce the severity of Covid-19 symptoms in vulnerable groups and help avoid hospital admissions.